11. Among the changes was elimination of a provision to stop the experiment if two patients experienced serious liver toxicity. 12. An internal review board was mixed on whether Togias should have stopped the experiment after the first subject developed symptoms. 13. An internal review was mixed on whether Togias should have stopped the experiment after the first subject developed symptoms. 14. But they added the experiment was stopped too early to determine whether it would grow into a viable embryo, much less a human fetus. 15. Even when the FDA stops an experiment because people have died, it seldom tells the public. 16. The university delayed telling FDA about the sick patients, but did do so six months before Gelsinger was treated and FDA never stopped the experiment, Tannen said. |